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Abstract
Background: The purpose of this study was to determine the one-year mortality rate and its predictors regarding
long-term intensive care-treated patients together with their health-related quality of life (HRQL), place of living,
healthcare use and long-term complication characteristics after intensive care unit (ICU) discharge.
Methods: A retrospective cohort study was performed in a 20-bed mixed ICU. The patients that were treated for
more than 72 h between 2007 and 2012 were included in this study. The one-year mortality rate was calculated,
and the characteristics of the ICU survivors that died within one year after ICU discharge were further analysed. For
all patients, the Dutch version of the SF-36 questionnaire was used to assess their current HRQL. The results were
compared with a normal population. Additionally, patients were questioned about their place of living, and their
general practitioners (GPs) were questioned about the patients’ possible long-term complications.
Results: Seven hundred and forty patients were included in this study, and their one-year mortality rate was 28 %,
of which half died within the first week after ICU discharge. The one-year mortality rate predictors included age at
the time of ICU admission, APACHE IV-predicted mortality score, number of comorbidities and ICU re-admissions.
The ICU survivor HRQL was significantly lower compared with the normal population. Half of the patients did not
return to their pre-hospital place of living, and numerous possible long-term complications were reported,
particularly decreased tolerance, chronic fatigue and processing problems of relatives.
Conclusions: One-year mortality rate of long-term ICU-treated patient was 28 %, and this was predicted by age,
disease severity, comorbidities and ICU re-admissions. The ICU survivors reported a lower HRQL, and a minority of
these patients returned home directly after hospital discharge; however, GPs reported numerous possible long-term
complications.
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Background
Intensive care (IC) therapy endpoints are traditionally
defined as the IC mortality rate, hospital mortality rate,
30-day mortality rate combined with mechanical ventila-
tion duration or the IC length of stay. Recently, the
long-term survival rate and health-related quality of life
(HRQL) outcomes have been identified as important
alternative IC therapy endpoint markers [1]. Further-
more, post-traumatic stress disorder (PTSD), neuromus-
cular problems and activity impairment are considered
long-term IC therapy complications [2, 3]. Previous
studies regarding IC therapy survival have focused on
total intensive care unit (ICU) patients, including post-
operative patients with short ICU stays [4, 5], or have
focused on specific populations, such as the elderly, can-
cer patients or mechanically ventilated patients [6–9].
Patient prognoses after long-term ICU stays (>72 h) are
unknown. The main objective of this retrospective
cohort study was to determine the long-term ICU-
treated patient one-year mortality rate and to define its
predictors. HRQL, place of living, healthcare use and
possible long-term complications were assessed in the
ICU survivors at 1, 2 and 5 years after ICU discharge.
Methods
Patients
This study was designed as a retrospective cohort study
and was conducted at the 20-bed mixed closed-format
ICU of the Onze Lieve Vrouwe Gasthuis in Amsterdam.
Inclusion criteria was: an ICU stay of >72 h. Our study
consisted of three cohorts, which were extracted from a
dataset of all admitted ICU patients who were treated for
more than 72 h between 1 January 2007 and 31 December
2007 (cohort 3), 1 June 2011 and 1 April 2012 (cohort 2)
and 1 June 2012 and 1 October 2012 (cohort 1).
Measurements
The death dates were obtained from the Dutch munici-
pal records which registers each death and links it to a
national database. Together with the hospital informa-
tion system Xcare, the ICU survivors’ survival statuses
were tracked. The ICU survivors that died within one
year after ICU discharge, in all cohorts, were further
analysed to identify any one-year mortality predictors.
The ICU survivors were contacted and asked to partici-
pate in this study. A written informed consent was ob-
tained from all participants. After permission was granted,
they received two questionnaires: the RAND-36 item
Health Survey (RAND-36) and a questionnaire that
evaluated where the patients were residing and their
healthcare use after hospital discharge. We also asked
for written permission to retrieve information from
their GPs regarding their long-term complications fol-
lowing IC therapy.
The RAND-36 is the Dutch language version of the
SF-36, which is a validated and reliable generic HRQL
measuring tool. This survey contains eight domains:
physical functionality, limitations due physical health
problems, bodily pain, general health perception, vitality,
social functionality, limitations due to emotional health
issues and general mental health. The bodily pain and
general health perception domains are not comparable
because of the differences between the RAND-36 and
SF-36 [10]. For that reason, we did not use these
domains in our analysis.
The questionnaire regarding home return and health-
care use after hospital discharge was developed by a
team of experts composed of ICU nurses, intensivists
and a clinical epidemiologist. The questionnaire con-
sisted of five closed questions about where the patients
were residing after hospital discharge and their health-
care use in the last 4 weeks.
The long-term complications questionnaire was devel-
oped following a literature research centred on long-term
complications after IC therapy and a focus group meet-
ing with GPs. It consisted of fifteen items and sub-
questions regarding possible complications that can
occur after IC therapy.
The following data were retrospectively collected for
each patient from the Patient Data Management Sys-
tem (PDMS) (iMD-soft; Metavision, Tel aviv, Israël):
gender, age at ICU admission, Body Mass Index, Acute
Physiology and Chronic Health Evaluation score IV
(APACHE), highest Sequential Organ Failure Assess-
ment score (SOFA), length of stay (LOS) at ICU, LOS
at hospital, mechanical ventilation duration (hours),
type of admission (defined as elective surgery, emer-
gency surgery and medical), presents of comorbidity,
presence of comorbidity (defined as present/yes of not
present/no), Continues Veno-Venous Hemofiltration
(CVVH) during ICU treatment yes/no, sepsis in the
first 24 h of the admission and readmission ICU after
initial ICU treatment.
To assess the illness severity, we used the APACHE IV
pm score [11]. To describe organ dysfunction/failure, we
used the SOFA score [12].
This study was approved by the Onze Lieve Vrouwe
Gasthuis Medical Ethics Committee in January 2013.
Statistical analyses
Statistical analyses were performed using the SPSS Pre-
dictive Analytics Software 20.0 (SPSS Inc., Chicago, IL).
All continuous and normally distributed data were
reported as mean ± standard deviation. Ordinal and non
normally distributed data were reported as median and
interquartile ranges. Data were summarised by frequencies
and percentages for the categorical variables. Predictors
were a priori defined as age and APACHE IV pm score.
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One year survivors and non-survivors were compared by
using chi-square test of Fisher’s exact test, Student’s t test
or Mann–Whitney rank-sum test as appropriate.
We included Age and APACHE IV pm and all vari-
ables with P ≤ 0.20 in the univariable analysis in the
multivariable Cox regression model, beginning the day
of ICU discharge until death within one year. The final
multivariable model was constructed by performing a
backward stepwise manual selection method. The
assumption of proportional hazards was graphically
tested with a log minus log survival plot. The hazard
ratio’s are reported with 95 % Confidence Interval
(CI). A p value less than 0.05 was considered statisti-
cally significant.
The RAND-36 scale scores of the respondents were con-
verted to a percentage ranging from 0 to 100, with higher
values indicating higher levels of functioning and well-
being. The mean RAND-36 scale scores were compared
with those of an age-matched Amsterdam general popula-
tion group with an independent t-test [13].
Results
Seven hundred and forty patients were treated for more
than 72 h in the ICU during the inclusion period. In total,
114 patients were included in cohort 1, 256 patients were
included in cohort 2 and 370 patients were included in
cohort 3. Of the 740 patients, 106 patients (14 %) died in
the ICU and another 85 patients (12 %) died during their
hospital stay after ICU discharge, resulting in a total of
191 in-hospital deaths (26 %) (Fig. 1).
The one-year ICU survivor mortality rate
Of the 634 ICU survivors, 17 patients were lost to follow
up, which left 617 patients for further analysis. Addition-
ally, 175/617 patients (28 %) died within the first year
after ICU discharge (Fig. 2). Of these 175 patients, 83
patients (47 %) died within the first week following ICU
discharge. Moreover, 65/83 (78 %) died during their stay
in our hospitals nursing ward. Additionally, 18/83 (22 %)
died outside of our hospital; however, it is unknown
whether they died at home, in another hospital or in a
temporarily health facility. Of the group who died during
the first week in the nursing ward, 7/65 (11 %) were
discharged from the ICU with palliative care, 35/65
(54 %) were discharged with any treatment restrictions
(from do-not-resuscitate orders to withholding of new
intensive care therapy), 8/65 (12 %) died during ICU re-
admission, and 12/65 (18 %) were discharged without an
apparent course. The ICU survivor baseline characteris-
tics are shown in Table 1. The age, APACHE IV pm,
SOFA score, ICU length of stay, mechanical ventilation,
admission type, comorbidity presence, CVVH and re-
admission values significantly differed between the survi-
vors and the non-survivors.
Multivariable Cox regression analysis identified four
independent predicting factors of one-year mortality after
ICU discharge, which included APACHE IV pm score
(OR: 1.02; 95 % CI: 1.01–1.02), age at the time of ICU
admission (OR: 1.02; 95 % CI: 1.00–1.03), re-admission
after ICU discharge within the same hospital stay period
(OR: 1.55; 95 % CI: 1.05–2.28), presence of comorbidities
(OR: 1.86; 95 % CI: 1.35–2.56), (Table 2). The survival
curve at mean of the covariates for time to one-year
mortality is shown in Fig. 2.
Health related quality of life
The HRQL questionnaire was sent to 305 survivors of
the three cohorts (1, 2 and 5 years after ICU dis-
charge), and 191 of these patients (63 %) completed
the questionnaire (Fig. 1). The RAND-36 scores are
summarised in Table 3. Of all the cohorts, the mean
values of the six analysed domains (physical function-
ality, physical role, social functionality, mental health,
emotional well-being and vitality) were significantly
lower than in the Amsterdam control group.
The place of residence and healthcare use after ICU
discharge
The questionnaire regarding home return and healthcare
use after hospital discharge was sent to the same 3
cohorts of 305 ICU survivors. A total of 190 (62 %) of
the survivors completed the questionnaire. 85/190 respon-
dents (45 %) did not return to their home situation after
ICU discharge, 47/85 (55 %) of these respondents were
transferred to a rehabilitation facility. Additionally, 68/
105 (65 %) of the respondents who did return to their
home situation were living independently. At the time
of this research, 180 (95 %) of the respondent ICU
survivors had a self-sufficient current living situation,
which included self-sufficiency with home- and/or in-
formal care. Additionally, 78 respondents (41 %) had an
appointment with their GP, 82 (43 %) met with a
medical specialist and 28 (15 %) met with a physiother-
apist within the last 4 weeks.
Long-term complications after an ICU stay
A total of 162/191 (85 %) respondents gave permission
to retrieve additional information from their GPs, and
95 GPs (59 %) responded to our questionnaire. The
possible long-term IC therapy complications that were
most frequently reported included general health com-
plaints about exercise tolerance (n = 42, 44 %), general
health complaints about chronic fatigue (n = 35, 37 %),
chronic renal insufficiency (n = 19, 20 %), an inability
to return to pre-ICU admission daily activities (n = 17,
18 %), processing problems of relatives (n = 14, 15 %),
anaemia (n = 14, 15 %) and congestive heart failure
(n = 13, 14 %).
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Discussion
The one-year post-ICU discharge mortality rate of the
patients who were treated for more than 72 h in the ICU
was 28 %, of which a large proportion died within the first
week after ICU discharge. The one-year mortality rates
were related to increased age at the time of ICU admission,
high APACHE IV-predicted mortality scores, presence of
comorbidities and ICU re-admission. Additionally, the ICU
survivors had a significantly lower HRQL compared to a
control group and a large number of these patients (45 %)
did not return directly to their home situations after
hospital discharge. Further, the most often reported long-
term ICU complications were decreased exercise tolerance,
chronic fatigue, processing family-related issues, an inability
to return to pre-ICU admission daily activities, anaemia,
renal insufficiency and congestive heart failure.
Fig. 2 Cox regression analysis one-year mortality after ICU discharge
Fig. 1 Flow diagram of the respondents. Survivors and non survivors one year after ICU discharge: survivors n (442) = a− c− d, non survivors n (175) = b+ c
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This research article is the first report of one-year
post-ICU discharge mortality rates in long-term treated
ICU patients. Most of the previous reports included the
one-year mortality rate of the total ICU patient popula-
tion. We choose to observe the group of patients with a
longer ICU stay, as they most likely suffered from a
higher illness severity level, making them at risk for
long-term complications. The mortality rates were, as
expected, lower (5–13 %) than in the previous studies
that included all IC patients, due to the presence of a
large cohort of post-surgical patients with low APACHE
pm scores [14–16]. In addition to the differences in the
patient populations (total versus long-term stay ICU
patients), the above-mentioned studies also differed in
design. Our study reports the one-year post-ICU
discharge mortality rate, whereas the others used the
one-year post-hospital discharge mortality rates. The
period after an ICU discharge, in particular, gives the
complete picture of the situation after ICU therapy, which
was of specific interest in our study, as explained in the
next paragraph.
A large proportion of the patients (47 %) died within the
first week of ICU discharge, which is comparable to the
Araújo et al. study [17]. A possible explanation for this
finding could be the decision to withhold or withdraw life-
sustaining treatments during a patient’s ICU stay as the
most powerful predictor of post-IC mortality, which was
reported previously [18]. Though the majority of patients
who died within the first week following ICU discharge
were discharged with any restriction for further medical
therapy, the number of patients discharged with palliative
care was limited. The patients with medical therapy
restrictions are most likely at higher risk for in-hospital
death due to their underlying diseases. Nevertheless, other
possible explanations include inappropriate triage before
ICU admission, ICU case-mix (e.g., increased age, several
comorbidities and illness severity), inappropriate post-ICU
care and lack of ICU capacity [19].
Table 2 Cox regression analysis: factors independently associated
with 1-year mortality after ICU discharge
95 % CI
Variables HR Lower Higher Significance
(p-value)
AGE 1,017 1,004 1,031 0,010
APACHE IV pm 1,018 1,013 1,023 0,000
Co-morbidity 1,857 1,348 2,559 0,000
ICU re-admission 1,555 1,055 2,285 0,026
HR Hazard Ratio, CI Confidence Interval ICU, Intensive Care U nit, APACHE IV
pm Acute Physiology and Chronic Health Evaluation, IV predicted mortality
Table 1 Baseline characteristics ICU survivors
Characteristics ICU survivors after 1 year n = 442 Non survivors after 1 year n = 175 p-value
Male/femalea 273 (61,8)/169 (38,2) 112 (63,6)/64 (36,7) .605c
Age (years)b 68 (58–75,3) 72 (63–77) .002d
BMI at admissionb 26,1 (23,4–29,8) 26,1 (23–30,4) .967d
APACHE-IV PM scoreb 14,4 (4,1–38,3) 41,4 (21,9–71,9) .0002d
Highest SOFA scoreb 8 (6–10) 9 (7–12) .0002d
ICU Lenght of stay LOS (days)b 6 (5–10) 8 (5–11) .011d
Hospital LOS (days)b 17 (11–31) 18 (11–33) .620d
Mechanical Ventilation (hours)b 56 (16,8–115) 90 (38–181) .000d
Admission type:a .000c
Medical 182 (41,2) 112 (64)
Elective Surgery 196 (44,3) 44 (25,7)
Emergency Surgery 64 (14,5) 18 (10,3)
Comorbiditya .000c
yes 205 (46,4) 118 (67,4)
no 237 (53,6) 57 (67,4)
CVVH during ICUa 77 (17,4) 53 (30,3) .001c
Sepsis at admission ICUa 66 (14,9) 25 (14,3) .938c
Re-admission ICU after initial ICU- treatmenta 47 (10,6) 32 (18,3) .015c
ICU Int ensive Care Unit, APACHE pm Acute Physiology and Chronic Health Evaluation, predicted mortality, SOFA Sequential Organ Failure Assessment,
CVVH Continuous Veno-Venous Hemofiltration
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The one-year mortality predictors included increased
age at the time of ICU admission, a high APACHE IV pm
score, presence of comorbidities and ICU re-admission.
Most of these predictors have been previously reported,
including age [5, 14, 16, 20, 21], comorbidity [14, 16, 21]
and illness severity [5, 6, 16, 18]. Additionally, a ‘sepsis’
diagnosis was found in previously studies to be associated
with an increased mortality rate in the first year after an
ICU stay [22]. This association was not observed in our
study, most likely because of the small population size and
the definition of sepsis. We only had valid data of the inci-
dence of sepsis in the first 24 h of the ICU admission.
Notably, re-admission was not previously reported.
The HRQL in the ICU survivors who were treated for
more than 72 h was evaluated using the RAND-36. This
study suggests that at three different cohorts after ICU
discharge, the ICU survivors had significantly lower
scores in six HRQL domains compared with the HRQL
of the age-matched Amsterdam study population group.
No studies were found that used the same follow-up
period and inclusion/exclusion criteria that we used.
Two systematic reviews used many studies that differ in
designs, patient populations, HRQL instruments, follow-
up times and response rates, although their overall find-
ings are consistent with our findings [23, 24]. Additionally,
a higher illness severity and a higher chronic health
burden may lead to a diminished HRQL [25, 26].
Many patients needed additional institutional and
home care after long-term IC therapy hospital dis-
charge, and a minority of the patients directly returned
home. This differs from a previous Australian study in
which a majority of the patients (82 %) returned to
their home after hospital discharge [27]. Both studies
are difficult to compare because of the differences in
the organisation of the healthcare systems between our
countries. Moreover, there are important post-hospital
healthcare organisation differences for the patients who
require long-term care between the Netherlands and
Australia [28]. The findings in our study could be
related to the wide gap between hospital and home care
after IC therapy, the ICU case-mix, and especially, the
lack of informal care culture in the Netherlands.
Finally, 97 % of the patients returned to their home
again, with or without home and informal care.
In the extensive long-term ICU complication survey,
which were reported by the GPs of the long-term
ICU-treated survivors, the following items were re-
ported: decreased exercise tolerance, chronic fatigue,
processing problems of relatives, an inability to return
to pre-ICU daily activities, anaemia, renal insufficiency
and congestive heart failure. Surprisingly, PTSD, the
most well-known long-term ICU stay complication,
was only reported in a minority of the patients. This
was most likely due to a difference in the PTSD diag-
noses between the GPs and the studies that reported
PTSD as common post-ICU complication [2]. Add-
itionally, it is possible that the ICU survivors that
would be diagnosed with PTSD using a validated
PTSD questionnaire, but the patient may not visit the
GPs with these problems because of fear, shame or did
not consider it a problem. More research regarding
long-term complications among ICU survivors is
needed to anticipate which interventions concern
post-ICU care.
Limitations
We acknowledge certain potential limitations in our
study. First, as a result of the retrospective observational
cohort design, we could not compare the RAND-36
results of our three cohorts to discern associations re-
garding the HRQL over time. In a prospective cohort
study, we would expect an HRQL improvement over
time because when a patient gets older or acquires a
chronic disease, he changes his internal standards and
Table 3 Scores on the RAND-36
Cohort 1 Cohort 2 Cohort 3 Control Group Amsterdam
T scoreb T scoreb T scoreb T scoreb T scoreb T scoreb Overall Age group (60–69)
Domains n = 40a x a n = 69a x a n = 82a x a x a
n = 4172a n = ±354a
Physical functioning 52.5 ± 30.4 −6.80c −4.64c 47.8 ± 29.9 −10.3c −7.40c 62.6 ± 27.8 −7.38c −4.00c 85.2 ± 23.1 74.8 ± 27.1
Role physical 44.7 ± 42.8 −5.01c −4.07c 45.9 ± 41.0 −6.72c −5.42c 54.5 ± 43.9 −5.03c −3.72c 79.5 ± 35.4 73.0 ± 39.7
Social functioning 65.9 ± 29.0 −4.18c −4.14c 67.8 ± 25.8 −5.53c −5.46c 74.1 ± 26.2 −3.79c −3.72c 85.1 ± 21.5 84.9 ± 22.9
Mental health 70.3 ± 20.5 −1.73 −2.62c 70.5 ± 20.7 −2.16c −3.32c 73.5 ± 17.6 −1.25 −2.73c 75.9 ± 17.0 78.8 ± 17.4
Role emotional 58.3 ± 44.6 −3.33c −3.64c 63.1 ± 41.8 −3.88c −4.30c 73.9 ± 40.4 −2.00c −2.48c 83.1 ± 32.7 85.3 ± 31.1
Vitality 54.5 ± 21.2 −4.20c −4.68c 54.1 ± 20.0 −6.00c −6.64c 57.8 ± 21.3 −4.52c −5.19c 68.6 ± 19.2 70.2 ± 20.4
Cohort 11 year after ICU discharge, Cohort 2 2 year after ICU discharge, Cohort 3 5 year after ICU discharge
aThe scores, which have a possible range of 0 to 100, are given as the mean and the standard deviation
bThe T score represents the comparison of the scores of a cohort and those of Amsterdam study: mean age (x) and Amsterdam study: age group 60–69 year (a)
cSignificance
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values and conceptualisation of HRQL [29]. This could
be either because the patients become accustomed to
their illness or chronic disease or because their expecta-
tions about their HRQL have changed [30]. Furthermore,
regarding the high first week post-ICU discharge mortality
rate analysis, we only had information for the patients
who stayed in our hospital. We had no access to the data
of the patients who were transferred to other hospitals.
Third, to understand an ICU patient HRQL, it is
important to know the patient’s baseline HRQL before
hospitalisation. Three methods are considered in esti-
mating the baseline HRQL status: 1) the age- and sex-
matched population normal values; 2) the patient/proxy
reports; and 3) the patient’s retrospective recall [31].
Because of the retrospective design of this study, we
chose to use an age-matched population normal value.
Additionally, we realised that this method and the
other abovementioned methods do not provide the
exact baseline HRQL of the ICU survivors. First, previ-
ous studies showed that ICU patients have lower base-
line HRQL levels than the normal population [26, 30].
Second, a patient’s retrospective baseline HRQL assess-
ment may suffer from recall bias [32]. Lastly, some
studies showed a poor to fair agreement of proxy versus
the patient HRQL assessments [26, 33]. Nonetheless,
we had to use one of these methods in the absence of a
better alternative, but we noticed that there was no
recent RAND-36 score with which to compare our
results. Third, the long-term complication question-
naire was designed as a screening instrument to iden-
tify long-term complications for further research and,
therefore, might be biased by the way the GPs mea-
sured post-ICU problems. Additionally, not all ICU
survivors may have visited their GPs with their post-IC
therapy complaints. Finally, the assumption of propor-
tional hazards may be violated because the curves for
re-admission crossed at the beginning of the graph
(Fig. 2). This may be due to the relatively high mortality
in the first week after ICU discharge. Future research
with a larger sample size should take this into account.
Conclusions
Of the long-term (>72 h) treated ICU patients, 28 % died
within one year after ICU discharge. Furthermore, half
of these patients died in the first week following ICU
discharge. Increased age at the time of ICU admission, a
high APACHE IV-predicted mortality score, presence of
co-morbidities and re-admission were associated with an
increased one-year mortality rate. Additionally, the ICU
survivors reported a lower HRQL, of which a minority
directly returned home after hospital discharge, and the
most commonly scored complications were decreased
exercise tolerance, chronic fatigue and processing prob-
lems of relatives.
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